Close

Analyst Ratings for BioCryst Pharma (BCRX)

BCRX Rating Summary

BCRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BCRX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $10.14 (+100.1%) * Over Last 12-Mos
Rating Score: 8.1 / 10   Percentile Rank: 85%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/20/2023 JPMorgan Jessica Fye New Coverage Overweight
(N/A)
10.00
(N/A)
5.14
(5.07)
-1.36% Details
9/18/2023 RBC Capital Brian Abraham Upgrade Outperform
(Sector Perform)
10.00
(9.00)
6.85
(5.07)
-25.99% Details
Like BCRX Ratings? Also take a look at CLSD

BCRX Ratings News